Patents by Inventor Michael Abecassis

Michael Abecassis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220205042
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Application
    Filed: August 13, 2021
    Publication date: June 30, 2022
    Inventors: Daniel R. Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • Patent number: 11104951
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: August 31, 2021
    Assignees: The Scripps Research Institute, Northwestern University
    Inventors: Daniel Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • Publication number: 20170183735
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Application
    Filed: May 22, 2015
    Publication date: June 29, 2017
    Inventors: Daniel R. Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • Publication number: 20110177959
    Abstract: Methods and devices for diagnosing, monitoring, or determining kidney transplant rejection or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining kidney transplant rejection or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described.
    Type: Application
    Filed: August 6, 2010
    Publication date: July 21, 2011
    Applicant: Rules-Based Medicine, Inc.
    Inventors: Michael D. Spain, James P. Mapes, Samuel T. Labrie, Ralph L. McDade, Dominic P. Eisinger, Karri L. Ballard, Daniel R. Salomon, Michael Abecassis
  • Publication number: 20060003828
    Abstract: A device for electronically communicating information relating to wagering for table games includes a plurality of player consoles, a dealer console and a processor is disclosed. Each player console, that includes a graphic display, is configured to debit a player's account, receive input relating to the wager and transmit the information to a central processor. The dealer console also has a processor that receives the wagering information from the players, displays the information and is configured to receive input relating to the game outcome for each respective player. In response to a winning event, the dealer console can transmit the wager result to said players' console and credit the account.
    Type: Application
    Filed: July 1, 2005
    Publication date: January 5, 2006
    Applicant: Mike Abecassis
    Inventor: Michael Abecassis